NASDAQ : ACLX
Arcellx, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 115.07 USD (Apr 27, 2026, 4:00 PM EDT) · Market cap 6.75B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Arcellx, Inc. (ACLX) reported revenue of 22.29M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 22.29M | 22.29M | 107.94M | 110.32M | ||
| Cost of Revenue | 157.61M | 157.61M | 157.09M | 133.85M | 149.56M | |
| Gross Profit | -135.32M | -135.32M | -49.16M | -23.53M | -149.56M | |
| Selling, General & Admin | 117.76M | 117.76M | 88.41M | 66.35M | 41.70M | 18.14M |
| Research & Development | 46.88M | |||||
| Operating Expenses | 117.76M | 117.76M | 88.41M | 66.35M | 41.70M | 65.02M |
| Operating Income | -253.08M | -253.08M | -137.57M | -89.88M | -191.26M | -65.02M |
| Interest Expense | -1.03M | -3.84M | -1.72M | -10.00K | ||
| Interest & Investment Income | 24.22M | 24.22M | 33.32M | 23.70M | 4.30M | 59.00K |
| Pretax Income | -228.87M | -228.87M | -105.28M | -70.03M | -188.68M | -64.97M |
| Income Tax Expense | 69.00K | 69.00K | 2.07M | 663.00K | ||
| Net Income | -228.93M | -228.93M | -107.35M | -70.69M | -188.68M | -64.97M |
| Net Income to Common | -228.93M | -228.93M | -107.35M | -70.69M | -188.68M | -64.97M |
| Shares Outstanding (Basic) | 56.31M | 56.31M | 53.57M | 48.06M | 36.36M | 446.38K |
| Shares Outstanding (Diluted) | 56.31M | 56.31M | 53.57M | 48.06M | 36.36M | 446.38K |
| EPS (Basic) | -4.07 | -4.07 | -2.00 | -1.47 | -5.19 | -145.55 |
| EPS (Diluted) | -4.07 | -4.07 | -2.00 | -1.47 | -5.19 | -145.55 |
| Free Cash Flow | -212.59M | -212.59M | -96.90M | 186.15M | -101.58M | -60.02M |
| Free Cash Flow Per Share | -3.78 | -3.78 | -1.81 | 3.87 | -2.79 | -134.46 |
| Gross Margin | -45.54% | -21.33% | ||||
| Operating Margin | -1,135.61% | -1,135.61% | -127.46% | -81.47% | ||
| Profit Margin | -1,027.26% | -1,027.26% | -99.45% | -64.08% | ||
| Free Cash Flow Margin | -953.89% | -953.89% | -89.78% | 168.73% | ||
| EBITDA | -246.41M | -246.41M | -132.38M | -87.84M | -189.94M | -63.98M |
| EBITDA Margin | -122.65% | -79.62% | ||||
| D&A For EBITDA | 6.68M | 6.68M | 5.19M | 2.04M | 1.32M | 1.04M |
| EBIT | -253.08M | -253.08M | -137.57M | -89.88M | -191.26M | -65.02M |
| EBIT Margin | -127.46% | -81.47% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 80.26M | 80.26M | 105.68M | 394.58M | 64.18M | 30.83M |
| Short-Term Investments | 370.07M | 370.07M | 481.70M | 307.43M | 190.66M | 73.78M |
| Cash & Short-Term Investments | 450.33M | 450.33M | 587.38M | 702.02M | 254.84M | 104.62M |
| Prepaid Expenses | 7.82M | 7.82M | 5.84M | 5.68M | 3.67M | 2.05M |
| Restricted Cash | 208.00K | 1.90M | ||||
| Other Current Assets | 4.03M | 4.03M | 5.88M | 6.76M | 8.36M | 6.14M |
| Total Current Assets | 462.18M | 462.18M | 599.31M | 716.36M | 266.86M | 112.81M |
| Property, Plant & Equipment | 66.47M | 66.47M | 70.25M | 69.83M | 39.89M | 10.32M |
| Long-Term Investments | 69.72M | 69.72M | 38.28M | 27.17M | ||
| Long-Term Deferred Charges | 3.01M | 3.01M | 1.08M | 9.36M | 4.56M | 5.46M |
| Other Long-Term Assets | 2.62M | 2.62M | 2.42M | 2.42M | 2.50M | 199.00K |
| Total Assets | 603.99M | 603.99M | 711.33M | 825.13M | 313.82M | 128.78M |
| Accounts Payable | 5.58M | 5.58M | 2.10M | 2.62M | 9.05M | 1.33M |
| Accrued Expenses | 29.52M | 29.52M | 35.48M | 18.30M | 11.68M | 11.88M |
| Current Portion of Leases | 7.58M | 7.58M | 7.54M | 46.78M | 35.96M | |
| Current Unearned Revenue | 55.97M | 55.97M | 59.06M | 50.53M | ||
| Other Current Liabilities | 5.56M | 5.56M | 21.24M | 1.63M | ||
| Total Current Liabilities | 104.20M | 104.20M | 125.41M | 118.24M | 56.69M | 14.85M |
| Long-Term Leases | 44.34M | 44.34M | 46.54M | 50.84M | 52.17M | |
| Long-Term Unearned Revenue | 53.10M | 53.10M | 76.00M | 170.67M | ||
| Other Long-Term Liabilities | 8.59M | 2.07M | ||||
| Total Liabilities | 201.64M | 201.64M | 256.54M | 339.75M | 108.86M | 16.92M |
| Common Stock | 56.00K | 56.00K | 53.00K | 52.00K | 44.00K | 1.00K |
| Additional Paid-In Capital | 1.13B | 1.13B | 950.72M | 874.26M | 523.92M | 8.62M |
| Retained Earnings | -725.76M | -725.76M | -496.83M | -389.48M | -318.79M | -130.11M |
| Comprehensive Income & Other | 843.00K | 843.00K | 848.00K | 547.00K | -221.00K | -20.00K |
| Total Common Equity | 402.35M | 402.35M | 454.79M | 485.38M | 204.95M | -121.52M |
| Shareholders' Equity | 402.35M | 402.35M | 454.79M | 485.38M | 204.95M | 111.86M |
| Total Liabilities & Equity | 603.99M | 603.99M | 711.33M | 825.13M | 313.82M | 128.78M |
| Total Debt | 51.92M | 51.92M | 54.08M | 97.62M | 88.13M | |
| Net Cash (Debt) | 468.13M | 468.13M | 571.57M | 631.56M | 166.70M | 104.62M |
| Net Cash Per Share | 8.31 | 8.31 | 10.67 | 13.14 | 4.59 | 234.37 |
| Filing Date Shares Outstanding | 58.48M | 58.48M | 54.94M | 52.80M | 47.84M | 35.74M |
| Total Common Shares Outstanding | 57.93M | 57.93M | 54.29M | 52.28M | 44.11M | 544.21K |
| Working Capital | 357.98M | 357.98M | 473.90M | 598.12M | 210.17M | 97.96M |
| Book Value Per Share | 6.95 | 6.95 | 8.38 | 9.28 | 4.65 | -223.29 |
| Tangible Book Value | 402.35M | 402.35M | 454.79M | 485.38M | 204.95M | -121.52M |
| Tangible Book Value Per Share | 6.95 | 6.95 | 8.38 | 9.28 | 4.65 | -223.29 |
| Machinery | 19.78M | 19.78M | 17.10M | 12.32M | 9.88M | 9.31M |
| Construction In Progress | 200.00K | 7.79M | 1.70M | 96.00K | ||
| Leasehold Improvements | 38.37M | 38.37M | 38.37M | 27.15M | 2.40M | 2.35M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -228.93M | -228.93M | -107.35M | -70.69M | -188.68M | -64.97M |
| Depreciation & Amortization | 6.68M | 6.68M | 5.19M | 2.04M | 1.32M | 1.04M |
| Loss (Gain) From Sale of Assets | 82.00K | 82.00K | -260.00K | 174.00K | 3.00K | 3.00K |
| Loss (Gain) From Sale of Investments | -8.44M | -8.44M | -15.46M | -11.05M | -2.12M | 210.00K |
| Stock-Based Compensation | 77.89M | 77.89M | 61.09M | 41.79M | 21.54M | 6.75M |
| Other Operating Activities | -38.00K | -38.00K | 4.10M | 19.88M | 64.18M | |
| Change in Accounts Payable | 2.66M | 2.66M | -70.00K | -6.47M | 7.42M | 974.00K |
| Change in Unearned Revenue | -25.99M | -25.99M | -86.15M | 221.21M | ||
| Change in Other Net Operating Assets | -34.17M | -34.17M | 55.45M | 10.70M | -2.97M | 1.75M |
| Operating Cash Flow | -210.26M | -210.26M | -83.47M | 207.57M | -99.30M | -54.24M |
| Capital Expenditures | -2.33M | -2.33M | -13.43M | -21.43M | -2.28M | -5.78M |
| Investment in Securities | 88.62M | 88.62M | -169.61M | -133.08M | -115.40M | -74.19M |
| Investing Cash Flow | 86.30M | 86.30M | -183.04M | -154.51M | -117.67M | -79.98M |
| Long-Term Debt Repaid | -230.00K | -230.00K | -39.85M | -29.39M | -9.68M | -387.00K |
| Net Debt Issued (Repaid) | -230.00K | -230.00K | -39.85M | -29.39M | -9.68M | -387.00K |
| Issuance of Common Stock | 137.19M | 137.19M | 15.76M | 308.56M | 262.30M | 432.00K |
| Repurchase of Common Stock | -38.42M | -38.42M | -24.00K | |||
| Other Financing Activities | -688.00K | |||||
| Financing Cash Flow | 98.53M | 98.53M | -24.09M | 279.16M | 252.62M | 118.45M |
| Net Cash Flow | -25.43M | -25.43M | -290.60M | 332.22M | 35.65M | -15.76M |
| Free Cash Flow | -212.59M | -212.59M | -96.90M | 186.15M | -101.58M | -60.02M |
| Free Cash Flow Margin | -953.89% | -953.89% | -89.78% | 168.73% | ||
| Free Cash Flow Per Share | -3.78 | -3.78 | -1.81 | 3.87 | -2.79 | -134.46 |
| Levered Free Cash Flow | -97.09M | -97.09M | 15.04M | 12.23M | -97.97M | -34.49M |
| Unlevered Free Cash Flow | -97.09M | -97.09M | 15.68M | 14.63M | -96.90M | -34.48M |
| Cash Income Tax Paid | 1.32M | 1.32M | 1.64M | 212.00K | ||
| Change in Working Capital | -57.49M | -57.49M | -30.78M | 225.43M | 4.45M | 2.72M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.75B | 3.77B | 4.15B | 2.88B | 1.36B | |
| Enterprise Value | 6.28B | 3.25B | 3.54B | 2.51B | 1.16B | |
| Last Close Price | 115.07 | 65.20 | 76.69 | 55.50 | 30.98 | |
| PS Ratio | 302.95 | 169.17 | 38.42 | 26.12 | ||
| PB Ratio | 16.57 | 9.37 | 9.12 | 5.94 | 6.63 | |
| P/TBV Ratio | 16.78 | 9.37 | 9.12 | 5.94 | 6.63 | |
| P/FCF Ratio | 15.48 | |||||
| P/OCF Ratio | 13.88 | |||||
| EV/Sales Ratio | 281.94 | 145.65 | 32.76 | 22.73 | ||
| EV/FCF Ratio | 13.47 | |||||
| Debt / Equity Ratio | 0.13 | 0.13 | 0.12 | 0.20 | 0.43 | |
| Debt / FCF Ratio | 0.52 | |||||
| Net Debt / Equity Ratio | -1.16 | -1.16 | -1.26 | -1.30 | -0.81 | -0.94 |
| Net Debt / EBITDA Ratio | 1.90 | 1.90 | 4.32 | 7.19 | 0.88 | 1.64 |
| Net Debt / FCF Ratio | 2.20 | 2.20 | 5.90 | -3.39 | 1.64 | 1.74 |
| Asset Turnover | 0.03 | 0.03 | 0.14 | 0.19 | ||
| Quick Ratio | 4.32 | 4.32 | 4.68 | 5.94 | 4.50 | 7.05 |
| Current Ratio | 4.43 | 4.43 | 4.78 | 6.06 | 4.71 | 7.60 |
| Return on Equity (ROE) | -53.42% | -53.42% | -22.84% | -20.48% | -119.11% | -80.01% |
| Return on Assets (ROA) | -24.05% | -24.05% | -11.19% | -9.86% | -54.02% | -43.58% |
| Return on Capital Employed (ROCE) | -50.60% | -50.60% | -23.50% | -12.70% | -74.40% | -57.10% |
| Earnings Yield | -3.39% | -6.07% | -2.59% | -2.45% | -13.89% | |
| FCF Yield | -3.15% | -5.64% | -2.34% | 6.46% | -7.48% | |
| Buyback Yield / Dilution | -5.11% | -5.11% | -11.45% | -32.20% | -8,044.59% | -56.02% |